LINTHICUM, Md., Jan. 18, 2005 (PRIMEZONE) -- Dialysis Corporation of America (Nasdaq:DCAI) announces the development of three new dialysis facilities in South Carolina, marking the start of the 2005 development cycle for the company and it's third and fourth facility in that state. One of the new facilities is an expansion of DCA's presence in Aiken, South Carolina, through the development of an additional dialysis center in that city to serve its growing number of patients.
President & CEO Stephen Everett stated, "We are thrilled to be continuing our growth in South Carolina, which is one of our key areas of focus. Our demonstrable dedication to superior quality care for the patients we are responsible for and the highest level of service to the physicians we are associated with, will continue to provide our company with opportunities and success in the markets we are committed to serve."
These new facilities will offer state-of-the-art equipment and technology, be designed with patient comfort in mind, and include 15-18 treatment stations in each facility.
Dialysis Corporation of America owns and operates freestanding kidney hemodialysis centers located in Georgia, Maryland, New Jersey, Ohio, Pennsylvania, South Carolina, and Virginia, and provides in-hospital dialysis services on a contract basis to certain hospitals located in the those states. The company provides patients with their choice of a full range of quality in-center, acute or at-home hemodialysis services.
This release contains forward-looking statements that are subject to risks and uncertainties that could cause actual results and plans to differ materially from those anticipated. Those factors include, but are not limited to, certain delays beyond the company's control with respect to future business events, the highly competitive environment in the establishment and operation of dialysis centers, the ability to develop or acquire additional dialysis facilities, whether patient bases of the company's facilities can expand to provide profitability, regulation of dialysis operations, government rate determination for Medicare reimbursement, and other risks detailed in the company's filings with the Securities and Exchange Commission, particularly as described in the company's annual report on Form 10-K for the fiscal year ended December 31, 2003. Other Dialysis Corporation of America press releases, corporate profile, corporate governance materials, quarterly and current reports, and other filings with the Securities and Exchange Commission are available on Dialysis Corporation of America's internet home page: http://www.dialysiscorporation.com.